KETamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest (OHCA) - the KETOHCA Trial

Phase: PHASE2 | Sponsor: Christian Hassager | Compound: Ketamine

Status

recruiting

Institution

Christian Hassager

Start date

2024-12-12

End date

2027-09-01

Registry ID

NCT06744361

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.